Invasive group B streptococcal disease: The emergence of serotype V

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 365-373

  Blumberg, Henry M ^a   Stephens, David S ^b   Modansky, Matthew ^b   Erwin, Melinda ^b   Elliot, John ^b   Facklam, Richard R ^b   Schuchat, Anne ^b   Baughman, Wendy ^b   Farley, Monica M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATION; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0030034829     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.365     Document Type: Article

References (13)

1. American Academy of Pediatrics, Committee on Infectious Diseases, Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
2. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1995;980-1054.
3. Institute of Medicine, National Academy of Sciences. New vaccine development: establishing priorities. Vol I. Diseases of importance in the United States. Washington, DC: National Academy Press 1985:424-39.
4. Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med 1990;322:1857-60.
5. Farley M, Harvey C, Stull T, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993;328:1807-11.
6. Schwartz B, Schuchat A, Oxtoby M, Cochi S, Hightower A, Broome C. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991;266:1112-4.
7. Wessels M, Kasper D. The changing spectrum of group B streptococcal disease. N Engl J Med 1993;328:1843-4.
8. Wilkinson HW, Eagon RG. Type-specific antigens of group B type Ic streptococci. Infect Immun 1971;4:596-604.
9. Colman G. Typing of Streptococcus agalactiae (Lancefield group B). Eur J Clin Microbiol Infect Dis 1988;7:226-31.
10. Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann 1993:22:711-4.
11. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B stieptococcal serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994;62:3236-43.
12. Baker CJ, Barrett FF. Group B streptococcal infections in infants: the importance of the various serotypes. JAMA 1974;230:1158-60.
13. Wilkinson HW, Facklam RR, Wortham EC. Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun 1973;8:228-35.